Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Semin Nucl Med. 2010 May;40(3):182–189. doi: 10.1053/j.semnuclmed.2009.12.004

Table 2.

FDA-approved antibodies for imaging cancer.

Generic name Trade name Target antigen Antibody format Radioiostope Indication
Arcitumomab CEA-Scan™; Immunomedics, Morris Plains, NJ CEA Fab 99mTc Colorectal cancer
Capromab pendetide ProstaScint™; Cytogen, Princeton, NJ PSMA IgG 111In Prostate cancer
Nofetumomab merpentan Verluma™; Boehringer Ingelheim, Ingelheim, Germany EpCAM Fab 99mTc Small cell lung cancer
Satumomab pendetide OncoScint™; Cytogen, Princeton, NJ TAG-72 IgG 111In Ovarian and colorectal cancer